相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical variables associated with PSA response to abiraterone acetate in patients with metastatic castration-resistant prostate cancer
R. Leibowitz-Amit et al.
ANNALS OF ONCOLOGY (2014)
Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Men With Metastatic Castration-Resistant Prostate Cancer
Guru Sonpavde et al.
CLINICAL GENITOURINARY CANCER (2014)
Optimal management of metastatic castration-resistant prostate cancer: Highlights from a European Expert Consensus Panel
John M. Fitzpatrick et al.
EUROPEAN JOURNAL OF CANCER (2014)
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer
Diletta Di Mitri et al.
NATURE (2014)
Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Men Treated With Second-Line Chemotherapy
Susan Halabi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study
David Olmos et al.
LANCET ONCOLOGY (2012)
Cancer Response Criteria and Bone Metastases: RECIST 1.1, MDA and PERCIST
Colleen M. Costelloe et al.
Journal of Cancer (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann Sebastian de Bono et al.
LANCET (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: Recommendations of the prostate cancer clinical trials working group
Howard I. Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
分享论文
